The DOI matches its Crossref record; 218 of the 228 references it cites were found in a registry or an index.
Microsatellite Instability in Colorectal Cancer
Open accessAbstract
Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, are commonly identified through separate MSI analysis and/or additional immunohistochemical staining for mismatch repair enzymes in pathology diagnostics2,3,51.”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“MSI-high tumors have been linked to a favorable prognosis2,51, characterized by lower differentiation grade, increased T-cell infiltration, and reduced susceptibility to invasiveness and KRAS mutation51”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
In the citing paper
“Microsatellite instability (MSI) caused by dysfunctional mismatch repair (dMMR) is detected in approximately 15% of all CRC and in nearly all cases with Lynch syndrome [126].”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Self-citation
Cited by
Sorted by citations
Items 101–200 of 1,002
Pérez–Carbonell, L., Ruíz-Ponte, C., Guarinós, C., Alenda, C., Payá, A., Brea‐Fernández, A., Egoavil, C. M., Castillejo, A., Barberá, V. M., Bessa, X., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300041 · Cited by 196
Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
Li, S. K. H., & Martín, A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.003 · Cited by 199
Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
Wang, W., Kandimalla, R., Huang, H., Zhu, L., Li, Y., Gao, F., Goel, A., & Wang, X. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.002 · Cited by 192
Self-citationEmerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Ahmad, R., Singh, J. K., Wunnava, A., Al-Obeed, O. A., Abdulla, M., & Srivastava, S. K. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4847 · Cited by 265
Recent progress in Lynch syndrome and other familial colorectal cancer syndromes
Boland, P. M., Yurgelun, M. B. B., & Boland, C. R. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21448 · Cited by 191
Self-citationImmunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches
Franke, A. J., Skelton, W. P., Starr, J. S., Parekh, H. D., Lee, J. J., Overman, M. J., Allegra, C. J., & George, T. J. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz093 · Cited by 189
Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., Cianciosi, D., Reboredo‐Rodríguez, P., Zhang, J., Manna, P. P., Daglia, M., Atanasov, A. G., et al. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.011 · Cited by 187
Molecular pathogenesis of sporadic colorectal cancers
Yamagishi, H., Kuroda, H., Imai, Y., & Hiraishi, H. (2016) · 癌症：英文版 · doi:10.1186/s40880-015-0066-y · Cited by 201
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine
Ogino, S., Fuchs, C. S., & Giovannucci, E. L. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.46 · Cited by 180
Jesinghaus, M., Konukiewitz, B., Keller, G., Kloor, M., Steiger, K., Reiche, M., Penzel, R., Endris, V., Arsenić, R., Hermann, G., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.220 · Cited by 177
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
Carethers, J. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i31.9253 · Cited by 185
Role of T lymphocytes in tumor response to radiotherapy
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00095 · Cited by 180
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study
Kloor, M., Huth, C., Voigt, A. Y., Benner, A., Schirmacher, P., Doeberitz, M. V. K., & Bläker, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70109-2 · Cited by 175
Interval cancers after negative colonoscopy: population-based case-control study
Brenner, H., Chang-Claude, J. C., Seiler, C. M., & Hoffmeister, M. (2011) · Gut · doi:10.1136/gutjnl-2011-301531 · Cited by 174
Xu, X., Lv, J., Guo, F., Li, J., Jia, Y., Jiang, D., Wang, N., Zhang, C., Kong, L., Liu, Y., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00814 · Cited by 173
“Recent clinical evidence has demonstrated that only a minority of patients with CRC demonstrated significant responses to PD-1 blockade (Lynch and Murphy, 2016), and these solitary patient with CRC who had responded to the PD-1 inhibitor were dMMR (also known as MSI) (Aguiar et al., 2015).”
BackgroundInfluentialWikberg, M. L., Edin, S., Lundberg, I. V., Guelpen, B. R. V., Dahlin, A. M., Rutegård, M., Stenling, R., Öberg, Å., & Palmqvist, R. (2013) · Tumor Biology · doi:10.1007/s13277-012-0638-2 · Cited by 177
Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo
Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S., & Engelward, B. P. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004901 · Cited by 169
The CpG island methylator phenotype (CIMP) in colorectal cancer.
Mojarad, E. N., Kuppen, P. J. K., Aghdaei, H. A., & Zali, M. R. (2013) · Europe PMC (PubMed Central) · Cited by 164
DNA replication fidelity and cancer
Preston, B. D., Albertson, T. M., & Herr, A. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.009 · Cited by 160
Microsatellite instability in colorectal cancer.
de’Angelis, G. L., Bottarelli, L., Azzoni, C., de’Angelis, N., Leandro, G., Mario, F. D., Gaiani, F., & Negri, F. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i9-s.7960 · Cited by 233
Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression
Pancione, M., Remo, A., & Colantuoni, V. (2012) · Pathology Research International · doi:10.1155/2012/509348 · Cited by 161
Microsatellite instability in colorectal cancer
Nojadeh, J. N., Sharif, S. B., & Sakhinia, E. (2018) · Europe PMC (PubMed Central) · doi:10.17179/excli2017-948 · Cited by 162
Sun, X., Zhan, L., Chen, Y., Wang, G., He, L., Wang, Q., Zhou, F., Yang, F., Wu, J., Wu, Y., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0011-z · Cited by 153
Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells
Lieb, S., Blaha-Ostermann, S., Kamper, E., Rippka, J., Schwarz, C., Ehrenhöfer-Wölfer, K., Schlattl, A., Wernitznig, A., Lipp, J., Nagasaka, K., et al. (2019) · eLife · doi:10.7554/elife.43333 · Cited by 151
Self-citationArvelo, F. A. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.520 · Cited by 163
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Vacante, M., Borzì, A. M., Basile, F., & Biondi, A. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i15.869 · Cited by 154
Impact of Gene–Environment Interactions on Cancer Development
Mbemi, A. T., Khanna, S. S., Njiki, S., Yedjou, C. G., & Tchounwou, P. B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218089 · Cited by 166
Boleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 153
Gut Microbiota, Fusobacteria, and Colorectal Cancer
Kelly, D., Yang, L., & Pei, Z. (2018) · Diseases · doi:10.3390/diseases6040109 · Cited by 152
Singh, M. P., Rai, S., Pandey, A., Singh, N. K., & Srivastava, S. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.013 · Cited by 167
Immunotherapy for Colorectal Cancer
Boland, P. M., & Ma, W. (2017) · Cancers · doi:10.3390/cancers9050050 · Cited by 149
Kloor, M., Reuschenbach, M., Pauligk, C., Karbach, J., Rafiyan, M., Al‐Batran, S., Tariverdian, M., Jäger, E., & Doeberitz, M. V. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3517 · Cited by 154
Mismatch repair deficiency: The what, how and why it is important
Olave, M. C., & Graham, R. P. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23015 · Cited by 158
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy
Du, W., Frankel, T. L., Green, M., & Zou, W. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00735-3 · Cited by 150
miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer
Oberg, A. L., French, A. J., Sarver, A. L., Subramanian, S., Morlan, B. W., Riska, S. M., Borralho, P. M., Cunningham, J. M., Boardman, L. A., Wang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020465 · Cited by 142
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
Chakrabarti, S., Peterson, C. Y., Sriram, D., & Mahipal, A. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i8.808 · Cited by 151
Multiple Instance Learning with Center Embeddings for Histopathology Classification
Chikontwe, P., Kim, M., Nam, S. J., Go, H., & Park, S. H. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-59722-1_50 · Cited by 145
The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
Jardim, S. R., de Souza, L. M. P., & de Souza, H. S. P. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043640 · Cited by 157
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Nebot-Bral, L., Brandão, D., Verlingue, L., Rouleau, É., Caron, O., Despras, E., Dakdouki, Y. E., Champiat, S., Aoufouchi, S., Leary, A. F., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.026 · Cited by 144
Molecular Pathology of Colorectal Cancer
Harada, S., & Morlote, D. M. (2019) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000247 · Cited by 153
Kang, S., Na, Y., Joung, S. Y., Lee, S. I., Oh, S. C., & Min, B. W. (2018) · Medicine · doi:10.1097/md.0000000000010019 · Cited by 151
Molecular tumour boards — current and future considerations for precision oncology
Tsimberidou, A. M., Kahle, M., Vo, H. H., Baysal, M. A., Johnson, A. M., & Meric‐Bernstam, F. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00824-4 · Cited by 145
Du, W., Hua, F., Li, X., Zhang, J., Li, S., Wang, W., Zhou, J., Wang, W., Liao, P., Yan, Y., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1571 · Cited by 141
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 138
Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review
Davri, A. S., Birbas, E., Kanavos, T., Ntritsos, G., Γιαννακέας, Ν., Tzallas, A. T., & Batistatou, A. K. (2022) · Diagnostics · doi:10.3390/diagnostics12040837 · Cited by 144
Luo, X.-J., Zhao, Q., Liu, J. S., Zheng, J., Qiu, M., Ju, H., & Xu, R. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.017 · Cited by 140
New insights into the mechanism of DNA mismatch repair
Reyes, G. X., Schmidt, T. T., Kolodner, R. D., & Hombauer, H. (2015) · Chromosoma · doi:10.1007/s00412-015-0514-0 · Cited by 143
Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.
Thanki, K. K., Nicholls, M. E., Gajjar, A. H., Senagore, A. J., Qiu, S., Szabó, C., Hellmich, M. R., & Chao, C. (2017) · PubMed · Cited by 136
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence
Belt, E. J. T., Fijneman, R. J. A., van den Berg, E. G., Bril, H., Diemen, P. M. D., Tijssen, M., Essen, H. F. H. V., Klerk, E. S. M. D. L., Beliën, J. A. M., Stockmann, H. B. A. C., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.025 · Cited by 132
The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
Sun, J., Fei, F., Zhang, M., Li, Y., Zhang, X., Zhu, S., & Zhang, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5663-8 · Cited by 133
Kooshkaki, O., Derakhshani, A., Hosseinkhani, N., Torabi, M., Safaei, S., Brunetti, O., Racanelli, V., Silvestris, N., & Baradaran, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124427 · Cited by 135
Natanzon, Y., Goode, E. L., & Cunningham, J. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.003 · Cited by 138
Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
Krasteva, N. A., & Georgieva, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061213 · Cited by 148
Kopetz, S., Tabernero, J. M., Rosenberg, R., Jiang, Z.-Q., Moreno, V. R., Bachleitner‐Hofmann, T., Lanza, G., Stork‐Sloots, L., Maru, D. M., Simón, I., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0325 · Cited by 130
Boland, C. R., & Lynch, H. T. (2013) · Familial Cancer · doi:10.1007/s10689-013-9637-8 · Cited by 145
Self-citationColon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 138
Williams, D. S., Bird, M., Jorissen, R. N., Yu, Y. L., Walker, F., Zhang, H. H., Nice, E. C., & Burgess, A. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0016012 · Cited by 128
Tumor-on-chip modeling of organ-specific cancer and metastasis
Piccolo, N. D., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 134
Characteristics and significance of colorectal cancer associated lymphoid reaction
Väyrynen, J. P., Väyrynen, S. A., Klintrup, K., Mäkelä, J. T., Herzig, K., Karttunen, T. J., Tuomisto, A., & Mäkinen, M. J. (2013) · International Journal of Cancer · doi:10.1002/ijc.28533 · Cited by 124
Berg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 129
Uncovering pseudotemporal trajectories with covariates from single cell and bulk expression data
Campbell, K. R., & Yau, C. (2018) · Nature Communications · doi:10.1038/s41467-018-04696-6 · Cited by 127
The impact of microsatellite stability status in colorectal cancer
Gupta, R., Sinha, S., & Paul, R. N. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.010 · Cited by 125
Carethers, J. M. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3443-5 · Cited by 126
de Salins, A. G. D., Tachon, G., Cohen, R., Karayan, L., Junca, A., Frouin, É., Godet, J., Evrard, C., Randrian, V., Duval, A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100120 · Cited by 123
Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors
Sourrouille, I., Coulet, F., Lefèvre, J. H., Colas, C., Eyries, M., Svrcek, M., Bardier–Dupas, A., Parc, Y. R., & Soubrier, F. (2012) · Familial Cancer · doi:10.1007/s10689-012-9568-9 · Cited by 120
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer
Zhang, J., Roberts, T. M., & Shivdasani, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.010 · Cited by 122
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
Snowsill, T., Huxley, N., Hoyle, M., Jones-Hughes, T., Coelho, H. F., Cooper, C., Frayling, I. M., & Hyde, C. (2014) · Health Technology Assessment · doi:10.3310/hta18580 · Cited by 119
Maak, M., Simón, I., Nitsche, U., Roepman, P., Snel, M. H. J., Glas, A. M., Schuster, T., Keller, G., Zeestraten, E. C. M., Goossens, I., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827c1180 · Cited by 120
Chen, B., Alvarado, D. M., Iticovici, M. S., Kau, N. S., Park, H., Parikh, P. J., Thotala, D. K., & Ciorba, M. A. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0282 · Cited by 119
Liu, X., Liu, Y., Liu, Z., Lin, C., Meng, F., Xu, L., Zhang, X., Zhang, C., Zhang, P., Gong, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01412-9 · Cited by 121
Animal models of colorectal cancer
Johnson, R. L., & Fleet, J. C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9404-6 · Cited by 125
Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers
Lee, S. Y., Haq, F. U., Kim, D., Jun, C., Jo, H.-J., Ahn, S., & Lee, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090459 · Cited by 117
Hodan, R., Gupta, S. N., Weiss, J. M., Axell, L., Burke, C. A., Chen, L.-M., Chung, D. C., Clayback, K. M., Felder, S. I., Foda, Z. H., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.0061 · Cited by 118
Ryan, É. J., Sheahan, K. D., Creavin, B., Mohan, H. M., & Winter, D. C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.05.006 · Cited by 121
Jm, B., Jh, K., Cho, N.-Y., Ty, K., & Kang, G. H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.430 · Cited by 115
Droeser, R. A., Hirt, C., Eppenberger‐Castori, S., Zlobec, I., Viehl, C. T., Frey, D. M., Nebiker, C. A., Rosso, R., Zuber, M., Amicarella, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064814 · Cited by 116
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells
Roumeliotis, T. I., Williams, S. P., Gonçalves, E., Alsinet, C., Velasco‐Herrera, M. D. C., Aben, N., Ghavidel, F. Z., Michaut, M., Schubert, M., Price, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.010 · Cited by 108
Shia, J., Schultz, N., Kuk, D., Vakiani, E., Middha, S., Segal, N. H., Hechtman, J. F., Berger, M. F., Stadler, Z. K., Weiser, M. R., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.198 · Cited by 105
Self-citationImportant molecular genetic markers of colorectal cancer
Kudryavtseva, A. V., Lipatova, A. V., Zaretsky, A. R., Moskalev, A., Fedorova, M., Poltavets, A. S., Shibukhova, G. A., Snezhkina, A. V., Каприн, А. Д., Alekseev, B. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9796 · Cited by 119
Apoptotic pathways as a therapeutic target for colorectal cancer treatment
Abraha, A. M., & Ketema, E. B. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i8.583 · Cited by 116
Sequencing and characterizing short tandem repeats in the human genome
Tanudisastro, H. A., Deveson, I. W., Dashnow, H., & MacArthur, D. G. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00692-3 · Cited by 125
Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer
Kastrinos, F., Samadder, N. J., & Burt, R. W. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.11.029 · Cited by 113
Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
Andrei, P., Battuello, P., Grasso, G., Rovera, E., Tesio, N., & Bardelli, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.007 · Cited by 116
Echle, A., Ghaffari Laleh, N., Quirke, P., Grabsch, H. I., Muti, H. S., Saldanha, O. L., Brockmoeller, S. F., van den Brandt, P. A., Hutchins, G. G. A., Richman, S. D., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100400 · Cited by 111
Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer
Baudrin, L. G., Deleuze, J., & How‐Kit, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00621 · Cited by 118
Thibaudin, M., Fumet, J.-D., Chibaudel, B., Bennouna, J., Borg, C., Martin-Babau, J., Cohen, R., Fonck, M., Taïeb, J., Limagne, E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02497-z · Cited by 117
Zou, J., Luo, H., Zeng, Q., Dong, Z., Wu, D., & Liu, L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-97 · Cited by 111
Zoratto, F., Rossi, L., Verrico, M., Papa, A., Basso, E., Zullo, A., Tomao, L., Romiti, A., Russo, G. L., & Tomao, F. (2014) · Tumor Biology · doi:10.1007/s13277-014-1845-9 · Cited by 112
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
Cheng, X. M., Wang, X., Nie, K., Cheng, L., Zhang, Z., Hu, Y., & Peng, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.646523 · Cited by 114
Yurgelun, M. B. B., Goel, A., Hornick, J. L., Sen, A., Turgeon, D. K., Ruffin, M. T., Marcon, N. E., Baron, J. A., Bresalier, R. S., Syngal, S., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0519 · Cited by 110
Self-citationNext-generation sequencing: recent applications to the analysis of colorectal cancer
Vecchio, F. D., Mastroiaco, V., Marco, A. D., Compagnoni, C., Capece, D., Zazzeroni, F., Capalbo, C., Alesse, E., & Tessitore, A. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1353-y · Cited by 110
Pernicka, J. S. G., Gagnière, J., Chakraborty, J., Yamashita, R., Nardo, L., Creasy, J. M., Petkovska, I., Do, R. R. K., Bates, . D. B., Paroder, V., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02117-w · Cited by 112
Genetic pathways, prevention, and treatment of sporadic colorectal cancer
Mundade, R., Imperiale, T. F., Prabhu, L., Loehrer, P. J., & Lu, T. (2014) · Oncoscience · doi:10.18632/oncoscience.59 · Cited by 109
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma
Tennstedt, P., Fresow, R., Simon, R., Marx, A. H., Terracciano, L., Petersen, C., Sauter, G., Dikomey, E., & Borgmann, K. (2012) · International Journal of Cancer · doi:10.1002/ijc.27907 · Cited by 109
Serrated polyposis: rapid and relentless development of colorectal neoplasia
Edelstein, D. L., Axilbund, J. E., Hylind, L. M., Romans, K. E., Griffin, C. A., Cruz–Correa, M., & Giardiello, F. M. (2012) · Gut · doi:10.1136/gutjnl-2011-300514 · Cited by 108
Wu, R., Wang, L., Yin, R., Hudlikar, R. R., Li, S. N., Kuo, H. D., Peter, R. M., Sargsyan, D., Guo, Y., Liu, X., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23146 · Cited by 108
Nahhas, O. S. M. E., van Treeck, M., Wölflein, G., Unger, M., Ligero, M., Lenz, T., Wagner, S. J., Hewitt, K. J., Khader, F., Foersch, S., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-01047-2 · Cited by 121
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
Gan, Y., Li, Y., Li, T., Shu, G., & Yin, G. (2018) · Cancer Management and Research · doi:10.2147/cmar.s176833 · Cited by 108
Use of molecular markers for predicting therapy response in cancer patients
Duffy, M. J., O’Donovan, N., & Crown, J. P. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.004 · Cited by 107
Barresi, V., Salinaro, A. T., Spampinato, G., Musso, N., Castorina, S., Rizzarelli, E., & Condorelli, D. F. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12060 · Cited by 105
Metadata
- Authors
- Boland, C. R., & Goel, A.
- Affiliations
- Baylor University Medical Center (US)
- Corresponding author
- Boland, C. Richard
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 138
- Issue
- 6
- Pages
- 2073-2087.e3
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3037515
- OpenAlex
- W2094390470
- Cited by
- 2,456
- References
- 228
- Citations by year
- 2026: 140 · 2025: 201 · 2024: 202 · 2023: 191 · 2022: 257 · 2021: 211 · 2020: 194 · 2019: 160 · 2018: 140 · 2017: 115 · 2016: 112 · 2015: 117 · 2014: 111 · 2013: 100 · 2012: 94
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01 CA129286, R01 CA72851)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, colorectal cancer, DNA mismatch repair, Lynch syndrome, MLH1 promoter methylation, CpG island methylator phenotype, proximal colon tumors, lymphocyte infiltration, mucinous tumors, signet ring cell carcinoma, prognosis, chemotherapy response
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Mutation, Phenotype, Risk Factors, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Treatment Outcome, Genetic Predisposition to Disease, Microsatellite Instability, DNA Mismatch Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
